Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
209.28B
Market cap209.28B
Price-Earnings ratio
11.12
Price-Earnings ratio11.12
Dividend yield
2.60%
Dividend yield2.60%
Average volume
12.98M
Average volume12.98M
High today
$47.65
High today$47.65
Low today
$46.54
Low today$46.54
Open price
$47.10
Open price$47.10
Volume
11.47M
Volume11.47M
52 Week high
$71.80
52 Week high$71.80
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 9h
Novo Nordisk Stock After Recent Pharma Sector Focus Is The Valuation Attractive

If you are wondering whether Novo Nordisk stock is starting to look attractively priced or still carries a premium, the current setup offers plenty of clues in...

Novo Nordisk Stock After Recent Pharma Sector Focus Is The Valuation Attractive
TipRanks 9h
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

24/7 Wall St. 1d
Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Novo Nordisk's US...

Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Analyst ratings

54%

of 37 ratings
Buy
37.8%
Hold
54.1%
Sell
8.1%

More NVO News

Nasdaq 1d
NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push

Novo Nordisk NVO shares gained 6.2% on Monday after the Novo Nordisk Foundation, the controlling shareholder of the Danish drugmaker, unveiled a major pan-Europ...

NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push
Nasdaq 2d
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

Key Points Viking Therapeutics has a weight-loss program that looks to be competitive with medicines already on the market. It's unclear how its candidate com...

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
Benzinga 2d
Novo Nordisk Stock Is Surging Monday: What's Driving The Action?

Novo Nordisk stock is showing exceptional strength. Why is NVO stock surging? What Is Driving Novo Nordisk’s Stock Rally? Novo Nordisk’s rally is landing in a m...

Novo Nordisk Stock Is Surging Monday: What's Driving The Action?
Simply Wall St 4d
Novo Nordisk Faces Cyber Breach While Pushing Oral Wegovy Into China

Novo Nordisk (NYSE:NVO) reported a material cybersecurity breach involving stolen patient, clinical, and proprietary data that attackers are seeking to monetize...

Novo Nordisk Faces Cyber Breach While Pushing Oral Wegovy Into China
Simply Wall St 4d
Why Hims & Hers Health Is Up 32.3% After Novo Nordisk GLP-1 Deal And Telehealth Push

In recent weeks, Hims & Hers Health has secured a partnership with Novo Nordisk to offer GLP-1 weight-loss drugs, completed the acquisition of digital health pl...

Why Hims & Hers Health Is Up 32.3% After Novo Nordisk GLP-1 Deal And Telehealth Push
The Motley Fool 4d
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?

Novo Nordisk (NVO 0.78%) kicked off a revolutionary shift in how obesity is treated. The goal, at first, was to help diabetics deal with weight loss, but the op...

Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?
Simply Wall St 5d
Novo Nordisk Stock Could Be 54.5% Undervalued After Its 90 Day Rebound

Novo Nordisk (NVO) continues to draw investor attention after recent share price moves, with the stock last closing at $43.19. The company’s performance metrics...

Novo Nordisk Stock Could Be 54.5% Undervalued After Its 90 Day Rebound

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.